Test Prices

An innovative blood test that determines biological age and the level of chronic inflammation based on the IgG glycan profile. The test reveals the impact of lifestyle factors (nutrition, sleep, stress, hormones) and provides personalized recommendations to improve long-term health.

An innovative genetic test that evaluates telomere length – one of the most important indicators of biological aging. The test helps assess the rate of aging and delivers personalized lifestyle recommendations to support healthy longevity.

An innovative genetic test analyzing over 100 single nucleotide polymorphisms (SNPs) related to dietary habits and food tolerance. The test evaluates both genetic predispositions and the patient’s current condition and goals.

An innovative genetic test analyzing 25 gene variants associated with physical performance, response to exercise, injury risk, and recovery. The test helps identify athletic potential and supports individualized training decisions.

A personalized pharmacogenetic test designed to identify the most effective treatment for different types of hair loss. The analysis includes 26 genetic markers, along with health and lifestyle factors.

A genetic test that helps personalize acne treatment based on the patient’s DNA. It analyzes 180 gene variants related to inflammation, hormonal balance, scarring, skin sensitivity, and treatment response.

An innovative genetic test that helps assess the risk of inherited conditions before pregnancy. The test determines whether prospective parents are carriers of genetic disorders, providing a basis for informed and responsible family planning.

An innovative genetic test that helps assess the risk of inherited conditions before pregnancy. The test determines whether prospective parents are carriers of genetic disorders, providing a basis for informed and responsible family planning.

An innovative genetic test that helps assess the risk of inherited conditions before pregnancy. The test determines whether prospective parents are carriers of genetic disorders, providing a basis for informed and responsible family planning.

A comprehensive genetic test that identifies the risk of 112 genetic conditions and 254 subtypes before symptoms appear. The test enables timely preventive medical action and provides valuable information for future family planning.

An expanded genetic test that assesses a newborn’s risk for up to 51 inherited metabolic disorders. The test allows early detection of potential metabolic abnormalities and timely preventive measures.

A reliable genetic test for pregnant women that enables safe and early assessment of the risk of fetal chromosomal abnormalities. The test is performed from the mother’s blood using advanced sequencing and bioinformatics methods

A reliable genetic test for pregnant women that enables safe and early assessment of the risk of fetal chromosomal abnormalities. The test is performed from the mother’s blood using advanced sequencing and bioinformatics methods.

An innovative genetic test designed to detect rare, clinically significant monogenic disorders that are often missed during routine screening. Performed from the mother’s blood, it offers high accuracy and can be done from the 10th week of pregnancy.

An innovative genetic test that helps personalize treatment based on a patient’s genetic profile. It analyzes genes affecting drug metabolism, effectiveness, and the risk of adverse reactions - supporting safer and more effective therapy.

An innovative genetic test that helps personalize treatment based on a patient’s genetic profile. It analyzes genes affecting drug metabolism, effectiveness, and the risk of adverse reactions - supporting safer and more effective therapy.

An innovative epigenetic methylation test that reliably assesses the risk of endometrial cancer. The test has a very high negative predictive value and helps avoid invasive diagnostic procedures.

A non-invasive methylation test that enables early detection of colorectal cancer or precancerous changes. Performed at home, it evaluates DNA changes associated with the presence of tumour cells.

An innovative non-invasive test for the early detection of oral squamous cell carcinoma (OSCC) and high-grade dysplasia. The test is based on epigenetic DNA methylation analysis of oral mucosal cells collected with a special brush - no incisions, no pain, no stress.

A comprehensive genetic test analysing mutations in 90 genes associated with 25 different cancer types. It helps identify inherited genetic risks and supports informed decisions on cancer prevention, early detection, or treatment adjustment.

An innovative genetic test that evaluates the expression of 50 tumour genes and helps estimate the risk of breast cancer recurrence over the next 10 years. The test supports selection of the most precise individual treatment plan, balancing treatment effectiveness with quality of life.

An innovative genetic test covering all coding gene regions and mitochondrial DNA. It helps identify the causes of rare inherited disorders even when symptoms are non-specific or cases are clinically complex.

An innovative genetic test covering all coding gene regions and mitochondrial DNA. It helps identify the causes of rare inherited disorders even when symptoms are non-specific or cases are clinically complex.

An innovative genetic test covering all coding gene regions and mitochondrial DNA. It helps identify the causes of rare inherited disorders even when symptoms are non-specific or cases are clinically complex.

The most comprehensive genetic test, enabling analysis of the entire human genome - including both coding and non-coding DNA regions. Used for diagnosing rare genetic disorders when other tests have not revealed the cause but a genetic basis is suspected.

The most comprehensive genetic test, enabling analysis of the entire human genome - including both coding and non-coding DNA regions. Used for diagnosing rare genetic disorders when other tests have not revealed the cause but a genetic basis is suspected.

The most comprehensive genetic test, enabling analysis of the entire human genome -including both coding and non-coding DNA regions. Used for diagnosing rare genetic disorders when other tests have not revealed the cause but a genetic basis is suspected.